ResearcherNo recent work listed

Tae-Jong Yoon

ORCID-verified (high confidence)As of 9 November 2026

Matched on ORCID iD 0000-0002-1605-2193; OpenAlex author ID A5035314152.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Collaborators: 2

Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

Gene Therapy Using Nanocarriers for Pancreatic Ductal Adenocarcinoma: Applications and Challenges in Cancer Therapeutics. Co-author DOI 10.3390/pharmaceutics14010137 ↗
One-shot dual gene editing for drug-resistant pancreatic cancer therapy. Last author DOI 10.1016/j.biomaterials.2021.121252 ↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Young-Seok Cho · 2 shared papers, 2021–2022
- Paper Gene Therapy Using Nanocarriers for Pancreatic Ductal Adenocarcinoma: Applications and Challenges in Cancer Therapeutic… DOI 10.3390/pharmaceutics14010137 ↗
- Paper One-shot dual gene editing for drug-resistant pancreatic cancer therapy. DOI 10.1016/j.biomaterials.2021.121252 ↗
Eun-Jeong Won · 2 shared papers, 2021–2022
- Paper Gene Therapy Using Nanocarriers for Pancreatic Ductal Adenocarcinoma: Applications and Challenges in Cancer Therapeutic… DOI 10.3390/pharmaceutics14010137 ↗
- Paper One-shot dual gene editing for drug-resistant pancreatic cancer therapy. DOI 10.1016/j.biomaterials.2021.121252 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.